3KH-30342-55765
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 957 / CA
- Registered
- 2021-05-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-03
Dose 1 — Pfizer-BioNTech
-
2021-05-11
Registered in v-safe
- 2021-05-11
- 2021-05-17
-
2021-05-24
Dose 2 — Pfizer-BioNTech
-
2021-05-24
Health check-in — day 0, dose 2Feeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-25
- 2021-05-26
- 2021-05-27
- 2021-05-28
- 2021-05-30
- 2021-05-31
- 2021-06-09
- 2021-06-14
- 2021-06-21
- 2021-06-28
- 2021-07-05
- 2021-08-23
- 2021-11-24
-
2022-05-24
Survey response — 12 months, dose 2MedDRA: Cough, Diarrhoea, Headache — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cough, headache, diarrheaMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-03 | Pfizer-BioNTech | |
| 2 | 2021-05-24 | Pfizer-BioNTech |
Free text
Release 11 — 12 months, dose 2
Symptoms: Cough, headache, diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release